Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Letrozole
Related studies linked through entity extraction aliases.
Abemaciclib and Letrozole to Treat Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Endometrial Preparation by Short Course of Letrozole Before Hysteroscopic Removal of Endocavitary Lesions
- Status
- UNKNOWN
- Phase
- PHASE4
Cost Effectiveness Analysis for Induction of Ovulation in the Polycystic Ovary Syndrome by Letrozole Versus Clomiphene Citrate
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Hormone Secretion in Transgender Males
- Status
- WITHDRAWN
- Phase
- PHASE4
Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
- Status
- UNKNOWN
- Phase
- NA
Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients
- Status
- COMPLETED
- Phase
- PHASE2
Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)
- Status
- TERMINATED
- Phase
- PHASE4
A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study
- Status
- TERMINATED
- Phase
- PHASE2
Different Protocols in Ovarian Stimulation in Intracytoplasmic Sperm Injection Cycles
- Status
- WITHDRAWN
- Phase
- NA
Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pharmacokinetics and Hepatic Safety of EGCG
- Status
- COMPLETED
- Phase
- PHASE1
Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy
- Status
- COMPLETED
- Phase
- N/A
IUI With Letrozole Versus in Natural Cycle
- Status
- RECRUITING
- Phase
- NA
Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1